Most Clicked StoriesMore >


Suspension of GVK-inspected medicines' sales sought by EMA

DIA Global SmartBrief | Jan 27, 2015

GVK Biosciences in Hyderabad, India, conducted flawed clinical studies of hundreds of drugs, according to the European Medicines Agency. The EMA has recommended suspending sales of the drugs. Belgium, Luxembourg and Germany are among the nations that suspended the approvals of GVK-tested drugs, sparking the EMA review. Wall Street Journal (tiered subscription model), The (01/23)


Report: FDA remains world's fastest in new drug approvals

DIA Global SmartBrief | Jan 27, 2015

Stakeholders debate informed consent guidance

DIA Global SmartBrief | Jan 22, 2015

Schizophrenia drug successful in Phase III trials

DIA Global SmartBrief | Jan 22, 2015

Obama announces initiative to expedite development of personalized cures

DIA Global SmartBrief | Jan 22, 2015

India may tie pricing to approvals of branded medicines

DIA Global SmartBrief | Jan 27, 2015

MedImmune to collaborate with National Cancer Institute on immunotherapies, technologies

DIA Global SmartBrief | Jan 27, 2015

Proposed bill would require pharma wrongdoers to fund government medical research

DIA Global SmartBrief | Jan 27, 2015

Delhi court orders generic drugmaker to stop selling, producing antibiotic

DIA Global SmartBrief | Jan 22, 2015

MSF wants drugmakers to slash vaccine prices

DIA Global SmartBrief | Jan 22, 2015


Find DIA Global SmartBrief Issues by Date:



DIA News More >


DIA membership

DIA Global SmartBrief | Jan 29, 2015

Let DIA deliver professional education and training to you and your team online

DIA Global SmartBrief | Jan 27, 2015

Help us recognize and award good work!

DIA Global SmartBrief | Jan 22, 2015

Transforming medical communications

DIA Global SmartBrief | Jan 20, 2015

DIA can bring outstanding training programs to your company

DIA Global SmartBrief | Jan 15, 2015




Sign up for DIA Global SmartBrief



Designed specifically for the global drug development professional, the DIA Global SmartBrief is a FREE, twice weekly e-mail newsletter. By providing the latest need-to-know industry news and information, the DIA Global SmartBrief saves you time and keeps you smart. Learn more